• Username (E-mail)
  • Password
Dow 21,141 1.6%  EStoxx50 3,390 2.1%  Nikkei 19,394 1.4%  EUR 1.0551 -0.2% 
Nasdaq 5,905 1.4%  FTSE100 7,383 1.6%  Yen 113.6540 0.7%  Oil 56.4 1.5% 
S&P500 2,398 1.4%  DAX 12,067 2.0%  GBP 1.2292 -0.7%  Gold 1,250 0.1% 

Hikma Pharmaceuticals share [ISIN: GB00B0LCW083]

Realtimequote Hikma Pharmaceuticals PLCShs in GBP

Exchange Market
21.73
Last
0
Volume
Time 11:29 AM
03/01/2017 11:29:48 AM UTC-0500
activate push

Stock Price Hikma Pharmaceuticals PLCShs in GBP

Activate push
21.72 GBP 0.22 GBP 1.02 %
Trade Time 4:35 PM Trade Date 3/1/2017
Daily High 21.80 Open 21.53
Daily Low 21.29 Prev. Close 21.50
52-week High 27.03 Volume (Qty.) 567,262
52-week Low 15.75 Market Cap (USD) 6.21 B
52-week Perf.
Exchange
The price of 21.72 GBP on the exchange London equals a price of 26.70 USD at the current exchange rate for GBP/USD.

Analyst Opinions for Hikma Pharmaceuticals PLCShs

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
10/10/11
Hikma Pharmaceuticals Citigroup Corp.

Moody's Rating for Hikma Pharmaceuticals PLCShs

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating
Rating Update
Date of Rating
Rating Office -

Profile Hikma Pharmaceuticals PLCShs

Company Profile
Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment offers selling of branded generics and in-licensed patented products. The Injectables segment includes manufacturing of sterile injectables. The Generics segment focuses on the U.S. market for oral generics. The Others segment comprises of Arab Medical Containers Ltd., International Pharmaceutical Research Center Ltd. and the chemicals division of Hikma Pharmaceuticals Ltd. (Jordan). The company was founded by Saaid Samih Taleb Darwazah in 1978 and is headquartered in London, the United Kingdom.
pagehit

Add or Edit Instrument

Hikma Pharmaceuticals Chart - 1 Year - LSE
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: LSE
  • Chart Options

Estimates for Hikma Pharmaceuticals

2015 2016e 2017e
Dividend 0.22 0.19 0.23
Dividend Yield in % 0.94 0.88 1.09
P/E Ratio 24.04 27.23 20.00
EPS 0.97 0.78 1.06

Hikma Pharmaceuticals Key Figures

Market Cap (USD) 6.21 B
Free Float in % 57.02
Number of Shares (Mio.) 239.97
Cash Flow per Share 1.25
Book Value per Share 4.58
60-Days Volatility 30.54
P/B Ratio 5.06

Base Data Hikma Pharmaceuticals

Symbol
ISIN GB00B0LCW083
Indices FTSE 100

About the Company Hikma Pharmaceuticals

Country Great Britain

Hikma Pharmaceuticals Historical Prices

02/27/2017
02/27/2017 06:00:00 PM UTC-0500
21.50 661,942
02/26/2017
02/26/2017 06:00:00 PM UTC-0500
21.10 368,274
02/23/2017
02/23/2017 06:00:00 PM UTC-0500
21.09 494,594
02/22/2017
02/22/2017 06:00:00 PM UTC-0500
20.68 389,232
02/21/2017
02/21/2017 06:00:00 PM UTC-0500
20.64 309,414

Hikma Pharmaceuticals Peer Group